Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 6 | 2024 | 347 | 0.950 |
Why?
|
| Blood Platelets | 4 | 2019 | 323 | 0.740 |
Why?
|
| RNA | 2 | 2020 | 552 | 0.660 |
Why?
|
| Mevalonic Acid | 1 | 2019 | 20 | 0.630 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2025 | 816 | 0.610 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2017 | 241 | 0.600 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 313 | 0.580 |
Why?
|
| Gene Expression Profiling | 10 | 2024 | 1883 | 0.570 |
Why?
|
| Cleft Palate | 3 | 2024 | 154 | 0.560 |
Why?
|
| Mitochondria | 1 | 2023 | 751 | 0.550 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2024 | 2850 | 0.550 |
Why?
|
| Breast Neoplasms | 4 | 2019 | 2676 | 0.540 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2017 | 36 | 0.540 |
Why?
|
| Paracrine Communication | 1 | 2017 | 70 | 0.520 |
Why?
|
| RNA Splice Sites | 1 | 2016 | 99 | 0.480 |
Why?
|
| Sequence Analysis, RNA | 7 | 2024 | 409 | 0.480 |
Why?
|
| Receptor, ErbB-2 | 1 | 2019 | 549 | 0.480 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 723 | 0.460 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 156 | 0.460 |
Why?
|
| Genomics | 1 | 2023 | 1652 | 0.450 |
Why?
|
| Transcriptome | 8 | 2024 | 1125 | 0.450 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 260 | 0.440 |
Why?
|
| Cleft Lip | 2 | 2024 | 135 | 0.380 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 946 | 0.340 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1829 | 0.310 |
Why?
|
| Pyrimidines | 2 | 2025 | 418 | 0.300 |
Why?
|
| Lung | 4 | 2024 | 1556 | 0.290 |
Why?
|
| Spliceosomes | 2 | 2021 | 54 | 0.280 |
Why?
|
| Signal Transduction | 2 | 2021 | 4718 | 0.280 |
Why?
|
| Cell Line, Tumor | 6 | 2025 | 3689 | 0.270 |
Why?
|
| Receptors, Thrombin | 2 | 2018 | 14 | 0.260 |
Why?
|
| Pyridines | 2 | 2018 | 249 | 0.250 |
Why?
|
| Citric Acid Cycle | 1 | 2025 | 46 | 0.240 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2025 | 31 | 0.240 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3358 | 0.230 |
Why?
|
| Adrenomedullin | 1 | 2024 | 80 | 0.200 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2024 | 211 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 608 | 0.170 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 149 | 0.170 |
Why?
|
| Keratin-8 | 1 | 2020 | 12 | 0.170 |
Why?
|
| Body Fluids | 1 | 2020 | 47 | 0.170 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2020 | 37 | 0.160 |
Why?
|
| Machine Learning | 2 | 2021 | 348 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 183 | 0.160 |
Why?
|
| Polymorphism, Genetic | 1 | 2023 | 803 | 0.160 |
Why?
|
| P-Selectin | 1 | 2019 | 68 | 0.160 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 141 | 0.160 |
Why?
|
| Pulmonary Fibrosis | 1 | 2020 | 112 | 0.150 |
Why?
|
| Humans | 23 | 2025 | 132238 | 0.150 |
Why?
|
| Trastuzumab | 1 | 2019 | 154 | 0.150 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 167 | 0.150 |
Why?
|
| Lactones | 1 | 2018 | 37 | 0.140 |
Why?
|
| Regeneration | 1 | 2020 | 225 | 0.140 |
Why?
|
| Brain Diseases | 1 | 2020 | 308 | 0.140 |
Why?
|
| Animals | 12 | 2025 | 34845 | 0.140 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2017 | 17 | 0.140 |
Why?
|
| Veratrum Alkaloids | 1 | 2017 | 13 | 0.140 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 273 | 0.130 |
Why?
|
| Alternative Splicing | 1 | 2019 | 364 | 0.130 |
Why?
|
| CELF1 Protein | 1 | 2016 | 48 | 0.130 |
Why?
|
| Heterografts | 1 | 2017 | 199 | 0.130 |
Why?
|
| Macrophages | 1 | 2021 | 692 | 0.130 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 316 | 0.130 |
Why?
|
| Apoptosis | 2 | 2021 | 1899 | 0.120 |
Why?
|
| Mice | 9 | 2025 | 18502 | 0.120 |
Why?
|
| Mice, SCID | 1 | 2017 | 604 | 0.120 |
Why?
|
| Genetic Variation | 2 | 2024 | 1580 | 0.120 |
Why?
|
| Interferons | 1 | 2017 | 142 | 0.120 |
Why?
|
| Genotype | 3 | 2018 | 2703 | 0.120 |
Why?
|
| Phosphorylation | 1 | 2019 | 1612 | 0.120 |
Why?
|
| Genes, myc | 1 | 2015 | 103 | 0.120 |
Why?
|
| Stem Cells | 1 | 2020 | 732 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2019 | 408 | 0.120 |
Why?
|
| Computational Biology | 2 | 2021 | 876 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2017 | 309 | 0.110 |
Why?
|
| Platelet Activation | 1 | 2014 | 69 | 0.110 |
Why?
|
| Platelet Aggregation | 1 | 2014 | 106 | 0.110 |
Why?
|
| Rotavirus Infections | 1 | 2017 | 359 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1249 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 689 | 0.100 |
Why?
|
| Genome-Wide Association Study | 2 | 2019 | 1831 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 1757 | 0.090 |
Why?
|
| Asthma | 1 | 2019 | 773 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1254 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 2442 | 0.090 |
Why?
|
| Alleles | 1 | 2016 | 1685 | 0.090 |
Why?
|
| Female | 10 | 2021 | 70780 | 0.090 |
Why?
|
| Biomarkers | 1 | 2020 | 3404 | 0.090 |
Why?
|
| Phenotype | 2 | 2020 | 4540 | 0.080 |
Why?
|
| Epithelial Cells | 3 | 2019 | 903 | 0.080 |
Why?
|
| Cell Communication | 2 | 2020 | 186 | 0.070 |
Why?
|
| Introns | 2 | 2021 | 305 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 207 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2021 | 247 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 4758 | 0.060 |
Why?
|
| Cell Survival | 2 | 2016 | 868 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2025 | 329 | 0.050 |
Why?
|
| Epigenomics | 1 | 2024 | 191 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 306 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2024 | 215 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 351 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 4687 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 66 | 0.040 |
Why?
|
| Chromatin | 1 | 2024 | 520 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2021 | 240 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 94 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2019 | 55 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 269 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2016 | 2680 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 5176 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 1018 | 0.040 |
Why?
|
| Lung Injury | 1 | 2020 | 123 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2019 | 188 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2019 | 107 | 0.040 |
Why?
|
| Metaplasia | 1 | 2019 | 217 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 403 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 237 | 0.030 |
Why?
|
| Collagen | 1 | 2019 | 303 | 0.030 |
Why?
|
| Mean Platelet Volume | 1 | 2017 | 4 | 0.030 |
Why?
|
| Software | 1 | 2022 | 732 | 0.030 |
Why?
|
| Cell Size | 1 | 2017 | 85 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 2017 | 44 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 806 | 0.030 |
Why?
|
| Proteome | 1 | 2019 | 278 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2017 | 172 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 105 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 503 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 559 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 289 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 218 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 10 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 9 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 62 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 53 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 66 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2018 | 244 | 0.030 |
Why?
|
| Ischemia | 1 | 2018 | 371 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 596 | 0.030 |
Why?
|
| Platelet Function Tests | 1 | 2014 | 41 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2018 | 517 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 387 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2024 | 2491 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 413 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1725 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 754 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 584 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 731 | 0.030 |
Why?
|
| Rotavirus | 1 | 2017 | 505 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1284 | 0.030 |
Why?
|
| Virus Replication | 1 | 2017 | 636 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 443 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 890 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 998 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 633 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 797 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2724 | 0.020 |
Why?
|
| Male | 4 | 2019 | 65013 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 21482 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1963 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2510 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2017 | 3868 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 1285 | 0.020 |
Why?
|
| Brain | 1 | 2020 | 3194 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 29021 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2062 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 6568 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 31614 | 0.010 |
Why?
|